Zobrazeno 1 - 10
of 114
pro vyhledávání: '"J. Kruser"'
Autor:
Seung Won Seol, Brian H. Lee, Timothy L. Sita, Jay Ram Devineni, Tim J. Kruser, Sean Sachdev, Michelle Gentile, Irene Helenowski, Bharat B. Mittal, MD
Publikováno v:
Physics and Imaging in Radiation Oncology, Vol 24, Iss , Pp 71-75 (2022)
This study aimed to assess the incidental radiation exposure of the hippocampus (HC) in locoregionally-advanced oropharyngeal cancer patients undergoing volumetric modulated arc therapy and the feasibility of HC-sparing plan optimization. The initial
Externí odkaz:
https://doaj.org/article/fc47da1b5b3f484d8069d7c95337a4b8
Autor:
Nawal Shaikh, Nupur Brahmbhatt, Tim J Kruser, Kwok L Kam, Christina L Appin, Nitin Wadhwani, James Chandler, Priya Kumthekar, Rimas V Lukas
Publikováno v:
CNS Oncology, Vol 8, Iss 3 (2019)
Pleomorphic xanthoastrocytoma (PXA) is a rare primary CNS tumor. Recent advances in the molecular characterization are helping to define subtypes of tumor. The discovery of BRAF mutations within a substantial percentage of PXA fosters a clearer under
Externí odkaz:
https://doaj.org/article/7e270781adc8417ca369c3bfbd8c0aed
Autor:
Nikhil, Rammohan, Alexander, Ho, Mohit, Saxena, Amishi, Bajaj, Tim J, Kruser, Craig, Horbinski, Alexander, Korutz, Matthew, Tate, Sean, Sachdev
Publikováno v:
Journal of Neuro-Oncology. 158:331-339
We investigated the prognostic significance of tumor-associated white matter (TA-WM) tracts in glioblastoma (GBM) using magnetic resonance-diffusion tensor imaging (MR-DTI). We hypothesized that (1) TA-WM tracts harbor microscopic disease not targete
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ffe5e89b1d471834d303a4d2feeedda
https://doi.org/10.1007/s11060-022-04018-3
https://doi.org/10.1007/s11060-022-04018-3
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 112:1067-1070
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2d3935f2e2541f88f64aefd4bf5aaff
https://doi.org/10.1016/j.ijrobp.2021.12.151
https://doi.org/10.1016/j.ijrobp.2021.12.151
Autor:
Paul M. Harari, Anthony Polverino, Angela Coxon, Johan Bussink, Albert J. van der Kogel, Kevin R. Kozak, Mari Iida, Eric A. Armstrong, Deric L. Wheeler, Tim J. Kruser
Background: Motesanib is a potent inhibitor of vascular endothelial growth factor receptors (VEGFR) 1, 2, and 3, platelet-derived growth factor receptor, and Kit receptors. In this report we examine the interaction between motesanib and radiation in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6432ed92edf953acfb29ea990d5bc328
https://doi.org/10.1158/1078-0432.c.6519156
https://doi.org/10.1158/1078-0432.c.6519156
Publikováno v:
Neuro-Oncology.
BackgroundBrain metastases are the most common intracranial tumors in adults and are associated with significant morbidity and mortality. Whole-brain radiotherapy (WBRT) is used frequently in patients for palliation, but can result in neurocognitive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b5e751fd7b4720d78e33e3928d97a4da
https://doi.org/10.1093/neuonc/noad029
https://doi.org/10.1093/neuonc/noad029
Autor:
Angela J. Fought, Karan Dixit, Vinai Gondi, Tim J. Kruser, Jeffrey Raizer, Minesh P. Mehta, Rimas V. Lukas, Sean Sachdev, Priya Kumthekar, Sean Grimm, Christina Amidei, Steven J. Chmura, Martin K. Nicholas
Publikováno v:
Journal of Neuro-Oncology. 155:297-306
Survival is dismal for bevacizumab refractory high-grade glioma patients. We prospectively investigated the efficacy of re-irradiation, bevacizumab, and temozolomide in bevacizumab-naive and bevacizumab-exposed recurrent high-grade glioma, without vo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6e6c2da30d30478e43a846b5de2ea31d
https://doi.org/10.1007/s11060-021-03875-8
https://doi.org/10.1007/s11060-021-03875-8
Autor:
Bradley T. Loeffler, Taher Abu Hejleh, Mary Pasquinelli, Timothy L. Sita, Ryan Nguyen, Sarah L. Mott, Tim J. Kruser, Muhammad Furqan, Adithya Chennamadhavuni, Nasser H. Hanna, Melissa Yan, Lawrence Eric Feldman, Nanmeng Yu, Josiah An
Publikováno v:
Translational Lung Cancer Research. 10:3608-3615
Background STK11 mutation (STK11m ) in patients (pts) with stage IV non-small cell lung cancer (NSCLC) is associated with inferior survival and poor response to immune checkpoint inhibitors (ICI). The significance of STK11m in stage III NSCLC pts tre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3ecd1ee7adfc7a01bf19cf21fc86b9f4
https://doi.org/10.21037/tlcr-21-177
https://doi.org/10.21037/tlcr-21-177
Autor:
Varun Padmanaban, Alireza Mansouri, Usman Beg, Nima Hamidi, Tim J. Kruser, Leonard Tuanquin, James R. Connor, Brianna Michelle Snyder, Sarosh Madhani
Publikováno v:
World Neurosurgery. 151:e839-e856
Background Radiation therapy (RT) is the cornerstone of management of malignant brain tumors, but its efficacy is limited in hypoxic tumors. Although numerous radiosensitizer compounds have been developed to enhance the effect of RT, progress has bee
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f89a58c5079685c9b3866d16aa66f12
https://doi.org/10.1016/j.wneu.2021.04.134
https://doi.org/10.1016/j.wneu.2021.04.134
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 110:257-260
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a5fba1a4501e936292b4b691dd8d0de9
https://doi.org/10.1016/j.ijrobp.2021.02.016
https://doi.org/10.1016/j.ijrobp.2021.02.016